https://www.selleckchem.com/products/gsk8612.html
Among those who tested positive, 9800 (18.0%) had been vaccinated; among those who tested negative, 17825 (32.8%) had been vaccinated. Overall vaccine effectiveness 7 or more days after the second dose was 97.1% (95% CI, 96.6% to 97.5%). Effectiveness was 96.2% (CI, 95.5% to 96.9%) for the Pfizer-BioNTech BNT-162b2 vaccine and 98.2% (CI, 97.5% to 98.6%) for the Moderna mRNA-1273 vaccine. Effectiveness remained above 95% regardless of age group, sex, race, or presence of comorbidities. Predominantly male population; lack of data on disea
Curtir
Comentario
Compartilhar
